Tessera Therapeutics Revenue and Competitors

Boston, MA USA

Location

$431.8M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Tessera Therapeutics's estimated annual revenue is currently $70.4M per year.(i)
  • Tessera Therapeutics's estimated revenue per employee is $155,000
  • Tessera Therapeutics's total funding is $431.8M.
  • Tessera Therapeutics's current valuation is $1.7B. (April 2022)

Employee Data

  • Tessera Therapeutics has 454 Employees.(i)
  • Tessera Therapeutics grew their employee count by 24% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5.2M67-45%$107.3MN/A
#2
$0.2M10%N/AN/A
#3
$4.2M2735%N/AN/A
#4
$11.9M77-37%$312.8MN/A
#5
$1.4M929%N/AN/A
#6
$235M255-31%$340.9MN/A
#7
$45.9M237-7%$7.6MN/A
#8
$3.9M5035%N/AN/A
#9
$5.3M340%N/AN/A
#10
$1.9M12-8%N/AN/A
Add Company

Our mission is to cure disease by writing the code of life

keywords:N/A

$431.8M

Total Funding

454

Number of Employees

$70.4M

Revenue (est)

24%

Employee Growth %

$1.7B

Valuation

N/A

Accelerator

Tessera Therapeutics News

2022-04-17 - Tessera Therapeutics Raises Over $300M in Series C Financing

Tessera Therapeutics, a Somerville, MA-based biotechnology company, raised over $300M in Series C funding.

2022-04-17 - Tessera Therapeutics stacks up more than $300M in series C funds ...

Tessera Therapeutics, founded and created by life sciences VC staple Flagship Pioneering, is building a war chest with a fresh $300 million...

2022-04-17 - Tessera Therapeutics Announces Over $300M Series C Financing ...

Tessera Therapeutics is pioneering GENE WRITING technology, which consists of multiple technology platforms designed to offer scientists and...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$99.8M4568%N/A
#2
$81.6M459-11%$502.5M
#3
$58.7M460N/AN/A
#4
$155.3M4710%$402.8M
#5
$108.5M48221%N/A